Clinical Research Web
Clinical Research
   Overview
Application Process
Researchers Toolkit

Policies and Guidelines

Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
   Development
Contracts Management
Review Committees
Funding News
Program Areas

Contact Us
My Privacy

NINDS is part of the
National Institutes of
Health

  Print-friendly version

   Email this page

The Office of the Inspector General (OIG) has developed several reports regarding human subject protection and the ethical conduct of clinical research. The following documents lists some of these reports that may provide useful information:

• Clinical Trial Web Sites: A Promising Tool to Foster Informed Consent (OEI-01-97-00198 May 2002)
• FDA Oversight of Clinical Investigators (OEI-05-99-00350 June 2000)
• Institutional Review Boards: The Emergence of Independent Boards (OEI-01-97-00192 June 1998)
• Institutional Review Boards: Their Role in Reviewing Approved Research (OEI-01-97-00190 June 1998)
• Institutional Review Boards: A Time for Reform (OEI-01-97-00193 June 1998)
• Institutional Review Boards: Promising Approaches (OEI-01-98-00191; 6/98)
• Protecting Human Research Subjects: Status of Recommendations (OEI-01-97-00197; 4/00)
• Recruiting Human Subjects: Pressures in Industry-Sponsored Clinical Research (OEI-01-97-00195 June 2000)
• Recruiting Human Subjects: Sample Guidelines for Practice (OEI-01-97-00196; 6/00)
• The Globalization of Clinical Trials: A Growing Challenge in Protecting Human Subjects (OEi-01-00-00190; 09/01)
• Recruiting Human Subjects: Pressures in Industry-Sponsored Clinical Research (OEI-01-97-00195; 6/00)

Related Information about NINDS Clinical Research
Policies and Regulatory Matters Regarding Human Subjects Research
Clinical Research General Information

Last updated April 20, 2007